{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:02:06Z","timestamp":1790276526085,"version":"4.1.0"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-induced osteomalacia (TIO) is an ultrarare paraneoplastic syndrome of abnormal phosphate and vitamin D metabolism secondary to the overproduction of fibroblast growth factor 23 by small-sized mesenchymal tumors typically located in soft tissues and bone. The tumor has adverse effects on bone and patients complain of skeletal symptoms and, in severe cases, they suffer multiple devastating fractures. Specific features may characterize the histology of tumors located in bone with respect to those found in extra-skeletal sites. Indeed, the matrix may contain foci resembling primitive cartilage and osteoid. Light microscopy of bone biopsy samples reveal accumulation of osteoid due to thickening of osteoid seams and, if tetracyclines were sequentially administrated, fluorescence microscopy reveals prolongation of the mineralization lag time. Areal BMD assessed by DXA is significantly lower at both the lumbar and femoral sites in patients with TIO and values of trabecular bone score are significantly reduced with respect to healthy individuals. Patients with TIO are also characterized by significant impairment in bone quality at both the trabecular and cortical compartment when evaluated by HR-pQCT. Successful surgical removal of the causative tumor completely reverts biochemical abnormalities. BMD accrual is impressive in the short term at the central (spine and hip) level but may take longer to improve, together with microstructural parameters, at peripheral sites (radius and tibia). Future studies should address effects of long-term treatment on quality-of-life outcomes related to irreversible events, such as vertebral fractures. This is particularly important in patients with a heavy burden due to a long-standing disease.<\/jats:p>","DOI":"10.1093\/jbmr\/zjaf148","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:20:50Z","timestamp":1760530850000},"page":"104-111","source":"Crossref","is-referenced-by-count":3,"title":["Skeletal involvement in tumor-induced osteomalacia"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-0439","authenticated-orcid":false,"given":"Salvatore","family":"Minisola","sequence":"first","affiliation":[{"name":"Department of Clinical, Internal, Anaesthesiologic and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome , 00161 Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Colangelo","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal, Anaesthesiologic and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome , 00161 Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1566-6553","authenticated-orcid":false,"given":"Jessica","family":"Pepe","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal, Anaesthesiologic and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome , 00161 Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-1202","authenticated-orcid":false,"given":"Cristiana","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal, Anaesthesiologic and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome , 00161 Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-4509","authenticated-orcid":false,"given":"Alessandro","family":"Corsi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Sapienza University of Rome , 00161 Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"2","key":"2026020308315752200_ref1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/endrev\/bnac026","article-title":"Tumor-induced osteomalacia: a comprehensive review","volume":"44","author":"Minisola","year":"2023","journal-title":"Endocr Rev"},{"issue":"1","key":"2026020308315752200_ref2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00223-025-01394-6","article-title":"Exploring the role of FGF7 in tumor-induced osteomalacia. Clinic-pathologic analysis in a patient with a sino-nasal phosphaturic mesenchymal tumor","volume":"116","author":"Colangelo","year":"2025","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2026020308315752200_ref3","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/JME-20-0121","article-title":"Extracellular phosphate sensing in mammals: what do we know?","volume":"65","author":"Beck","year":"2020","journal-title":"J Mol Endocrinol"},{"issue":"7","key":"2026020308315752200_ref4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"issue":"3","key":"2026020308315752200_ref5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/joim.13593","article-title":"Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia","volume":"293","author":"Jan de Beur","year":"2023","journal-title":"J Intern Med"},{"issue":"4","key":"2026020308315752200_ref6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00223-022-01005-8","article-title":"Tumor-induced osteomalacia: a systematic clinical review of 895 cases","volume":"111","author":"Bosman","year":"2022","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"2026020308315752200_ref7","doi-asserted-by":"crossref","first-page":"e3428","DOI":"10.1210\/clinem\/dgac253","article-title":"Tumor-induced osteomalacia: a systematic review and individual patient's data analysis","volume":"107","author":"Rendina","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026020308315752200_ref8","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2026020308315752200_ref9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nutres.2013.10.010","article-title":"Acute exposure to high-fat diets increases hepatic expression of genes related to cell repair and remodeling in female rats","volume":"34","author":"Miller","year":"2014","journal-title":"Nutr Res"},{"issue":"4","key":"2026020308315752200_ref10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.semdp.2019.07.002","article-title":"Phosphaturic mesenchymal tumors: a review and update","volume":"36","author":"Folpe","year":"2019","journal-title":"Semin Diagn Pathol"},{"issue":"9","key":"2026020308315752200_ref11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00198-022-06432-9","article-title":"A literature review to understand the burden of disease in people living with tumour-induced osteomalacia","volume":"33","author":"Minisola","year":"2022","journal-title":"Osteoporos Int"},{"issue":"1","key":"2026020308315752200_ref12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/clinem\/dgae431","article-title":"Healthcare resource use associated with tumor-induced osteomalacia: a literature review","volume":"110","author":"Jan de Beur","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020308315752200_ref13","first-page":"554","article-title":"Rickets following bone tumor","volume":"14","author":"Prader","year":"1959","journal-title":"Helv Paediatr Acta"},{"issue":"1","key":"2026020308315752200_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"7746","key":"2026020308315752200_ref15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(72)92844-9","article-title":"Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia","volume":"1","author":"Evans","year":"1972","journal-title":"Lancet"},{"issue":"14","key":"2026020308315752200_ref16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM197204062861402","article-title":"\u201cTertiary\u201d hyperparathyroidism and apparent \u201ccure\u201d of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx","volume":"286","author":"Olefsky","year":"1972","journal-title":"N Engl J Med"},{"issue":"8","key":"2026020308315752200_ref17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"key":"2026020308315752200_ref18","author":"Folpe AL","year":"2013"},{"issue":"1","key":"2026020308315752200_ref19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.anl.2008.01.003","article-title":"Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue","volume":"36","author":"Uramoto","year":"2009","journal-title":"Auris Nasus Larynx"},{"issue":"2","key":"2026020308315752200_ref20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002560000306","article-title":"Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia","volume":"30","author":"Ogose","year":"2001","journal-title":"Skeletal Radiol"},{"issue":"9","key":"2026020308315752200_ref21","first-page":"1860","article-title":"Malignant phosphaturic mesenchymal tumor of the larynx","volume":"121","author":"Sidell","year":"2011","journal-title":"Laryngoscope."},{"issue":"11","key":"2026020308315752200_ref22","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.humpath.2013.04.027","article-title":"Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis","volume":"44","author":"Uchihashi","year":"2013","journal-title":"Hum Pathol"},{"issue":"4","key":"2026020308315752200_ref23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.anndiagpath.2012.06.005","article-title":"Phosphaturic mesenchymal tumor: a report of 6 patients treated at a single institution and comparison with reported series","volume":"17","author":"Fatani","year":"2013","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"2026020308315752200_ref24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3892\/ol.2014.2081","article-title":"Malignant phosphaturic mesenchymal tumor of the pelvis: a report of two cases","volume":"8","author":"Morimoto","year":"2014","journal-title":"Oncol Lett"},{"issue":"12","key":"2026020308315752200_ref25","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00256-015-2246-x","article-title":"Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia","volume":"44","author":"Higley","year":"2015","journal-title":"Skeletal Radiol"},{"issue":"1","key":"2026020308315752200_ref26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12891-017-1446-z","article-title":"A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia","volume":"18","author":"Arai","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"17","key":"2026020308315752200_ref27","doi-asserted-by":"crossref","first-page":"e6750","DOI":"10.1097\/MD.0000000000006750","article-title":"Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: a case report","volume":"96","author":"Qiu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"2026020308315752200_ref28","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","article-title":"RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia","volume":"33","author":"Bahrami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"2026020308315752200_ref29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13000-016-0477-3","article-title":"Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant","volume":"11","author":"Shiba","year":"2016","journal-title":"Diagn Pathol"},{"issue":"10","key":"2026020308315752200_ref30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","article-title":"Phosphaturic mesenchymal Tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic Spectrum","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"2026020308315752200_ref31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.humpath.2018.02.022","article-title":"Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the \u201cnonphosphaturic\u201d variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization","volume":"80","author":"Sent-Doux","year":"2018","journal-title":"Hum Pathol"},{"issue":"4","key":"2026020308315752200_ref32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"issue":"11","key":"2026020308315752200_ref33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"key":"2026020308315752200_ref34","first-page":"284","volume-title":"WHO Classification of Tumours Editorial Board, ed. Soft Tissue and Bone Tumours. WHO Classification of Tumours, 5th ed. Vol 3","author":"Lee","year":"2020"},{"key":"2026020308315752200_ref35","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026020308315752200_ref36","doi-asserted-by":"crossref","first-page":"101772","DOI":"10.1016\/j.bonr.2024.101772","article-title":"Tumor-induced osteomalacia: a systematic literature review","volume":"21","author":"Alvarez-Rivas","year":"2024","journal-title":"Bone Rep"},{"issue":"11","key":"2026020308315752200_ref37","doi-asserted-by":"crossref","first-page":"NP714","DOI":"10.1177\/01455613221149635","article-title":"Non-phosphaturic\u201d variant of Phosphaturic mesenchymal tumor of the middle ear expressing multiple Phosphatonins","volume":"104","author":"Palmisano","year":"2025","journal-title":"Ear Nose Throat J"},{"issue":"2","key":"2026020308315752200_ref38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41379-018-0100-0","article-title":"Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review","volume":"32","author":"Wu","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"2026020308315752200_ref39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000000290","article-title":"A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors","volume":"39","author":"Carter","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2026020308315752200_ref40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"2026020308315752200_ref41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.33549\/physiolres.933843","article-title":"Involvement of bone in systemic endocrine regulation","volume":"67","author":"Zofkova","year":"2018","journal-title":"Physiol Res"},{"issue":"10","key":"2026020308315752200_ref42","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00256-017-2698-2","article-title":"Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune-Albright syndrome","volume":"46","author":"Corsi","year":"2017","journal-title":"Skeletal Radiol"},{"issue":"4","key":"2026020308315752200_ref43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00223-018-0429-x","article-title":"A challenging case of tumor-induced osteomalacia: pathophysiological and clinical implications","volume":"103","author":"Colangelo","year":"2018","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2026020308315752200_ref44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/S0004-27302010000200002","article-title":"Bone histomorphometry: a concise review for endocrinologists and clinicians","volume":"54","author":"Kulak","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"2026020308315752200_ref45","doi-asserted-by":"crossref","first-page":"907914","DOI":"10.3389\/fendo.2022.907914","article-title":"Interest of bone histomorphometry in bone pathophysiology investigation: foundation, present, and future","volume":"13","author":"Chavassieux","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026020308315752200_ref46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jbmr.4197","article-title":"Clinical phenotype and relevance of LRP5 and LRP6 variants in patients with early-onset osteoporosis (EOOP)","volume":"36","author":"Sturznickel","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2026020308315752200_ref47","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jbmr.4325","article-title":"Impaired bone microarchitecture and strength in patients with tumor-induced osteomalacia","volume":"36","author":"Zanchetta","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026020308315752200_ref48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40618-022-01918-z","article-title":"High prevalence of vertebral deformity in tumor-induced osteomalacia associated with impaired bone microstructure","volume":"46","author":"Ni","year":"2023","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"2026020308315752200_ref49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(87)90075-1","article-title":"Tumor-induced osteomalacia. Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry","volume":"82","author":"Siris","year":"1987","journal-title":"Am J Med"},{"issue":"23","key":"2026020308315752200_ref50","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199406093302304","article-title":"Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia","volume":"330","author":"Cai","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"2026020308315752200_ref51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ki.2008.355","article-title":"Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis","volume":"76","author":"Gore","year":"2009","journal-title":"Kidney Int"},{"issue":"4","key":"2026020308315752200_ref52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00223-009-9216-z","article-title":"Effects of tumor-induced osteomalacia on the bone mineralization process","volume":"84","author":"Nawrot-Wawrzyniak","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2026020308315752200_ref53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jbmr\/zjae008","article-title":"Approaching virtual osteoid volume estimation and in-depth tissue characterization in patients with tumor-induced osteomalacia","volume":"39","author":"Schmidt","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2026020308315752200_ref54","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.1997.12.9.1502","article-title":"Tumor-induced osteomalacia: clinical and basic studies","volume":"12","author":"Shane","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2026020308315752200_ref55","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance","volume":"37","author":"Hidaka","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026020308315752200_ref56","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jbmr\/zjae046","article-title":"Bone biopsy for the diagnosis of osteomalacia. Can we avoid it?","volume":"39","author":"Zanchetta","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026020308315752200_ref57","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1302\/0301-620X.105B5.BJJ-2022-1206.R2","article-title":"Patterns of symptoms and insufficiency fractures in patients with tumour-induced osteomalacia","volume":"105-B","author":"Kobayashi","year":"2023","journal-title":"Bone Joint J"},{"key":"2026020308315752200_ref58","doi-asserted-by":"crossref","first-page":"116064","DOI":"10.1016\/j.bone.2021.116064","article-title":"Challenges in the management of tumor-induced osteomalacia (TIO)","volume":"152","author":"Brandi","year":"2021","journal-title":"Bone"},{"issue":"1","key":"2026020308315752200_ref59","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-13-0581","article-title":"Six-year follow-up of a characteristic osteolytic lesion in a patient with tumor-induced osteomalacia","volume":"170","author":"Piemonte","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026020308315752200_ref60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jbmr.4476","article-title":"Bone impairment in a large cohort of Chinese patients with tumor-induced osteomalacia assessed by HR-pQCT and TBS","volume":"37","author":"Ni","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026020308315752200_ref61","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00198-020-05369-1","article-title":"Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia","volume":"31","author":"Colangelo","year":"2020","journal-title":"Osteoporos Int"},{"issue":"3","key":"2026020308315752200_ref62","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jbmr.2176","article-title":"Trabecular bone score: a noninvasive analytical method based upon the DXA image","volume":"29","author":"Silva","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026020308315752200_ref63","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cen.14533","article-title":"Microarchitectural parameters and bone mineral density in patients with tumour-induced osteomalacia by HR-pQCT and DXA","volume":"95","author":"Mendes","year":"2021","journal-title":"Clin Endocrinol"},{"key":"2026020308315752200_ref64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12891-015-0496-3","article-title":"Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors","volume":"16","author":"Sun","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"2026020308315752200_ref65","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1177\/02841851231160086","article-title":"Imaging characteristics of phosphaturic mesenchymal tumors","volume":"64","author":"Gupta","year":"2023","journal-title":"Acta Radiol"},{"issue":"11","key":"2026020308315752200_ref66","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/CM9.0000000000001448","article-title":"Consensus on clinical management of tumor-induced osteomalacia","volume":"134","author":"Jiang","year":"2021","journal-title":"Chin Med J"},{"issue":"5","key":"2026020308315752200_ref67","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jos.2020.07.006","article-title":"Surgical margin for phosphaturic mesenchymal tumors in soft tissues: an analysis of the radiological histopathological correlation","volume":"26","author":"Kobayashi","year":"2021","journal-title":"J Orthop Sci"},{"issue":"2","key":"2026020308315752200_ref68","doi-asserted-by":"crossref","first-page":"101834","DOI":"10.1016\/j.beem.2023.101834","article-title":"Tumor-induced osteomalacia: an overview","volume":"38","author":"Jadhav","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2026020308315752200_ref69","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.3903","article-title":"Nonremission and recurrent tumor-induced osteomalacia: a retrospective study","volume":"35","author":"Li","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026020308315752200_ref70","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jjco\/hyad180","article-title":"Extended curettage for tumour-induced osteomalacia in the bone","volume":"54","author":"Okajima","year":"2024","journal-title":"Jpn J Clin Oncol"},{"issue":"11","key":"2026020308315752200_ref71","doi-asserted-by":"crossref","first-page":"e1365","DOI":"10.1210\/clinem\/dgad252","article-title":"Shift in calcium from peripheral bone to axial bone after tumor resection in patients with tumor-induced osteomalacia","volume":"108","author":"Ni","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026020308315752200_ref72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00223-009-9275-1","article-title":"Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases","volume":"85","author":"Rendina","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2026020308315752200_ref73","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1210\/clinem\/dgad430","article-title":"Skeletal perturbations following sudden stimuli","volume":"109","author":"Minisola","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026020308315752200_ref74","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2026020308315752200_ref75","doi-asserted-by":"crossref","first-page":"101758","DOI":"10.1016\/j.bonr.2024.101758","article-title":"Healing of tumor-induced osteomalacia as assessed by high-resolution peripheral quantitative computed tomography is not similar across the skeleton in the first years following complete tumor excision","volume":"21","author":"Salles, Rosa Neto","year":"2024","journal-title":"Bone Rep"},{"issue":"2","key":"2026020308315752200_ref76","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.4184","article-title":"Interim analysis of a phase 2 open-label trial assessing Burosumab efficacy and safety in patients with tumor-induced osteomalacia","volume":"36","author":"Imanishi","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026020308315752200_ref77","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2026020308315752200_ref78","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/jbmr.4318","article-title":"Burosumab for tumor-induced osteomalacia: not enough of a good thing","volume":"36","author":"Hartley","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026020308315752200_ref79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00198-022-06516-6","article-title":"Long-term use of burosumab for the treatment of tumor-induced osteomalacia","volume":"34","author":"Crotti","year":"2023","journal-title":"Osteoporos Int"},{"issue":"2","key":"2026020308315752200_ref80","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00198-022-06617-2","article-title":"Appropriate dosing of burosumab in tumor-induced osteomalacia","volume":"34","author":"Colangelo","year":"2023","journal-title":"Osteoporos Int"},{"issue":"8","key":"2026020308315752200_ref81","doi-asserted-by":"crossref","first-page":"e10661","DOI":"10.1002\/jbm4.10661","article-title":"Infigratinib reduces fibroblast growth factor 23 (FGF23) and increases blood phosphate in tumor-induced osteomalacia","volume":"6","author":"Hartley","year":"2022","journal-title":"JBMR Plus"},{"issue":"2","key":"2026020308315752200_ref82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2213-8587(19)30426-7","article-title":"Approach to patients with hypophosphataemia","volume":"8","author":"Florenzano","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"14","key":"2026020308315752200_ref83","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMc2020399","article-title":"Targeted FGFR blockade for the treatment of tumor-induced osteomalacia","volume":"383","author":"Hartley","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjaf148\/64710639\/zjaf148.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/2\/104\/64710639\/zjaf148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/2\/104\/64710639\/zjaf148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:32:14Z","timestamp":1770125534000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/41\/2\/104\/8286789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2026,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjaf148","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,15]]}}}